Cargando…

FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1

SIMPLE SUMMARY: Current approaches to treat cancer include eg. targeted therapies, employing agents, such as antibodies, aimed directly at molecules expressed in cancerous cells. Here we present a targeting molecule alternative to antibodies-peptibodyF2-composed of a peptide responsible for its targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jendryczko, Karolina, Chudzian, Julia, Skinder, Natalia, Opaliński, Łukasz, Rzeszótko, Jakub, Wiedlocha, Antoni, Otlewski, Jacek, Szlachcic, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602595/ https://www.ncbi.nlm.nih.gov/pubmed/33076489 http://dx.doi.org/10.3390/cancers12102992

Ejemplares similares

Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Jendryczko, Karolina, et al.
Publicado: (2021)

Drug Conjugation via Maleimide–Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies
por: Jendryczko, Karolina, et al.
Publicado: (2022)

FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation
por: Szlachcic, Anna, et al.
Publicado: (2012)

FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1
por: Świderska, Karolina Weronika, et al.
Publicado: (2018)

Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling
por: Zakrzewska, Malgorzata, et al.
Publicado: (2019)

Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin
por: Zakrzewska, Malgorzata, et al.
Publicado: (2009)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Szymczyk, Jakub, et al.
Publicado: (2021)

Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
por: Chudzian, Julia, et al.
Publicado: (2018)

Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2017)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
por: Lipok, Magdalena, et al.
Publicado: (2019)

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
por: Szymczyk, Jakub, et al.
Publicado: (2022)

Roles of the FGF-FGFR Signaling System in Cancer Development and Inflammation
por: Wiedlocha, Antoni, et al.
Publicado: (2021)

Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity
por: Szlachcic, Anna, et al.
Publicado: (2019)

High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1
por: Opaliński, Łukasz, et al.
Publicado: (2018)

Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing Cancers
por: Porębska, Natalia, et al.
Publicado: (2021)

Intracellular FGF1 protects cells from apoptosis through direct interaction with p53
por: Lampart, Agata, et al.
Publicado: (2023)

Nuclear Localization Sequence of FGF1 Is Not Required for Its Intracellular Anti-Apoptotic Activity in Differentiated Cells
por: Lampart, Agata, et al.
Publicado: (2022)

The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
por: Poźniak, Marta, et al.
Publicado: (2021)

Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity
por: Opaliński, Łukasz, et al.
Publicado: (2017)

FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
por: Sochacka, Martyna, et al.
Publicado: (2020)

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1)
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2020)

The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
por: Karsten, Lennard, et al.
Publicado: (2022)

Nucleolin Regulates Phosphorylation and Nuclear Export of Fibroblast Growth Factor 1 (FGF1)
por: Sletten, Torunn, et al.
Publicado: (2014)

Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
Publicado: (2021)

Bioengineered peptibodies as blockers of ion channels
por: Chidipi, Bojjibabu, et al.
Publicado: (2022)

FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
por: Pozniak, Marta, et al.
Publicado: (2020)

Large‐scale production, purification, and function of a tumor multi‐epitope vaccine: Peptibody with bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020)

FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
por: Sochacka, Martyna, et al.
Publicado: (2022)

Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
por: Zukowska, Dominika, et al.
Publicado: (2023)

Guanidine-modified albumin-MMAE conjugates with enhanced endocytosis ability
por: Yi, Ce, et al.
Publicado: (2023)

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
por: Gregorczyk, Paulina, et al.
Publicado: (2023)

Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway
por: Szybowska, Patrycja, et al.
Publicado: (2019)

Fibroblast Growth Factor 2 Conjugated with Monomethyl Auristatin E Inhibits Tumor Growth in a Mouse Model
por: Krzyscik, Mateusz A., et al.
Publicado: (2021)

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
por: Poźniak, Marta, et al.
Publicado: (2021)

Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
por: Szybowska, Patrycja, et al.
Publicado: (2021)

Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
por: Jurek, Przemysław M, et al.
Publicado: (2017)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Expression, purification and biological activity assessment of romiplostim biosimilar peptibody
por: Fayaz, Shima, et al.
Publicado: (2016)

Old Drug, New Delivery Strategy: MMAE Repackaged
por: Lahnif, Hanane, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ocfdh04hb1ai3coopvfm11k82e